To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis
Phase 3
Withdrawn
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: NYC 0462 OintmentDrug: Placebo
- First Posted Date
- 2008-09-04
- Last Posted Date
- 2012-05-07
- Lead Sponsor
- Fougera Pharmaceuticals Inc.
- Registration Number
- NCT00747032
Cutivate Lotion HPA Axis Pediatric Study
- First Posted Date
- 2007-10-18
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- Fougera Pharmaceuticals Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT00546000
- Locations
- 🇺🇸
Centre for Health Care Medical Associates, Poway, California, United States
🇺🇸University of Miami, Dept. of Dermatology, Miami, Florida, United States
🇺🇸Dermatology Center for Children and Young Adults, Eagan, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath